Recherche
-
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationLibre accès -
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
(Nature Communications. vol. 14, n° 1, pp. 2303, 2023-04-21)Article de revueLibre accès -
Out-of-Pocket Expenses in Households of People Living with Obesity in France
(Obesity Facts. vol. 16, n° 6, pp. 606-613, 2023)Article de revueLibre accès -
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
(Cells. vol. 12, n° 15, pp. 1927, 2023-07-25)Article de revueLibre accès -
Linking emotional valence and anxiety in a mouse insula-amygdala circuit
(Nature Communications. vol. 14, n° 1, pp. 5073, 2023-08-21)Article de revueLibre accès -
Bitter taste cells in the ventricular walls of the murine brain regulate glucose homeostasis
(Nature Communications. vol. 14, n° 1, 2023-03-22)Article de revueLibre accès -
An enquiry to the role of CB1 receptors in neurodegeneration
(Neurobiology of Disease. vol. 184, 2023-08)Article de revueLibre accès -
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment
(Neurology(R) neuroimmunology & neuroinflammation. vol. 10, n° 6, 2023-09-22)Article de revueLibre accès -
Lifespan neurodegeneration of the human brain in multiple sclerosis
(Human Brain Mapping. vol. 44, n° 17, pp. 5602-5611, 2023-03-14)Article de revueLibre accès